Presentation Information
[2-MO17-2]SPECT/CT Imaging and Dosimetry of [211At]NaAt in Patients with Refractory Thyroid Cancer
Tadashi Watabe1、Hidetaka Sasaki2、Takashi Kamiya2、Kosuke Mukai1、Sadahiro Naka2、Atsunori Fukuhara1、Yoshifumi Shirakami1、Kazuhiro Ooe1、Kayako Isohashi1、Iichiro Shimomura1、Noriyuki Tomiyama1 (1.The University of Osaka, Osaka, Japan、2.The University of Osaka Hospital, Osaka, Japan)
